Jonathan Hirsch serves as the Chief Strategy and Growth Officer at Paradigm since March 2022, focusing on creating equitable access to clinical trials by alleviating the burden on physicians. In addition, Jonathan co-founded and currently serves as the Chair of the Advisory Board for Synapticure Inc. and holds several investment roles, including Seed Investor at Protege and Investor at multiple companies such as Arbital Health, Frame, and Thyme Care. Jonathan is also an Advisor for Viz.ai, a Strategic Advisor and Investor for Osmind, and a Partner at Rebel Fund. Educational qualifications include a Master of Science in Biological Sciences from Stanford University and a Bachelor of Arts in Biology and Political Science from the University of Chicago.
This person is not in the org chart
This person is not in any teams
This person is not in any offices